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Background: The ability to return to work after infective endocarditis (IE) holds important 
socioeconomic consequences for both patients and society, yet data on this issue are sparse. 
We examined return to the workforce and associated factors in IE patients of working age. 
Methods and results: Using Danish nationwide registries, we identified 1065 patients aged 
18-60 years with a first-time diagnosis of IE (1996-2013) who were part of the workforce 
prior to admission and alive at discharge. One year after discharge, 765 (71.8%) patients had 
returned to the workforce, 130 (12.2%) were on paid sick leave, 76 (7.1%) received disability 
pension, 23 (2.2%) were on early retirement, 65 (6.1%) had died, and 6 (0.6%) had 
emigrated. Factors associated with return to the workforce were identified using multivariable 
logistic regression. Younger age (18-40 versus 56-60 years; odds ratio, 2.85; 95% confidence 
interval, 1.71-4.76) and higher level of education (higher educational level versus basic 
school; 5.47,2.05-14.6) and income (highest quartile versus lowest; 3.17,1.85-5.46) were 
associated with return to the workforce. Longer length of hospital stay (>90 versus 14-30 
days; 0.16,0.07-0.38), stroke during IE admission (0.38,0.21-0.71), and a history of chronic 
kidney disease (0.29,0.11-0.75), chronic obstructive pulmonary disease (0.31,0.13-0.71), and 
malignancy (0.39,0.22-0.69) were associated with a lower likelihood of returning to the 
workforce. 
Conclusions: Seven out of ten patients who were part of the workforce prior to IE and alive at 
discharge were part of the workforce one year later. Younger age, higher socioeconomic 
status, and absence of major comorbidities were associated with return to the workforce. 
 



















Despite major advances in diagnostic imaging, antimicrobial therapy, and surgical treatment, 
infective endocarditis (IE) remains a disease with high morbidity and mortality.
1, 2
 As 
survivors may be left with life-changing physical and mental disabilities, traditional outcome 
measures such as mortality, morbidity, and serious adverse events do not provide a complete 
assessment of the consequences of the disease.
3
 Hence, a more comprehensive assessment 
should include outcomes of recovery and function at home and in society including quality of 
life and return to work.
4-6
 Employment is important for physical and mental health, self-
esteem, and social identity, but work capability also provides financial independence and 
economic contribution to the society.
7-11
 Identifying patients at high risk of workforce 
detachment is of great importance and may aid in forestalling the aggravation of symptoms 
by providing better and more focused care. However, the ability to return to work after IE has 
only been sparsely investigated.
3
 To address these issues, we conducted a nationwide cohort 
study in Denmark to examine return to the workforce and associated factors in patients with 
first-time IE of working age. 
 
Methods 
The Danish healthcare and social welfare systems 
The Danish healthcare system, funded by taxes, provides free and equal access to healthcare 
for all residents regardless of employment status. Similarly, social welfare benefits and social 
services, also financed by taxes, are provided to residents whenever indicated. These benefits 
include, but are not limited to, state educational grants, unemployment benefits, and disability 
pension. In Denmark, all residents are offered a fully state-funded pension at the age of 65 or 




















All residents in Denmark are assigned a unique and permanent civil registration number 
allowing accurate linkage of nationwide administrative registries at an individual level. The 
Danish registry on all public welfare benefits holds information on all Danish residents who 
have received public welfare benefits at any time on a weekly basis since 1991.
12, 13
 The 
Danish National Patient Registry contains information on all hospital admissions since 1977 
and all surgical procedures since 1996. Each admission is registered by one primary diagnosis 
and, if appropriate, one or more secondary diagnosis according to the International 
Classification of Diseases (ICD-8 until 1993 and ICD-10 from 1994) and operations are 
classified according to the NOMESCO Classification of Surgical Procedures (NCSP). The 
diagnosis of IE in patients below 60 years of age has been validated with a positive predictive 
value of 88% in the Danish National Patient Registry.
14
 The Danish National Prescription 
Registry holds detailed information on all claimed drug prescriptions dispensed from 
pharmacies in Denmark.
15
 Information on vital status was obtained from the Danish National 
Population Registry,
16






All Danish residents with a first-time diagnosis of IE between January 1, 1996 and December 
31, 2013 were identified. Only patients of working age between 18 and 60 years, who were 
part of the workforce 30 days prior to admission and alive at discharge after IE were included 




















Comorbidity was defined using hospital discharge diagnoses any time prior to and including 
index hospitalization for IE (Supplementary Table 1 for ICD-8 and ICD-10 codes). Patients 
with diabetes and hypertension were identified using claimed drug prescriptions as done 
previously.
19, 20
 Stroke during admission was defined using hospital discharge diagnoses 
during index hospitalization. In addition, Charlson Comorbidity Index was calculated as 
described previously to quantify the burden of comorbidities at discharge (Supplementary 
Table 2 for the weight of each comorbidity).
21
 Patients with a harlson Comorbidity Index 
greater than 2 were considered as having significant comorbidities. Surgical procedures were 
assessed prior to and during index hospitalization. Concomitant pharmacotherapy was 
defined by claimed prescriptions within 180 days prior to admission for IE (Supplementary 
Table 3 for ATC codes). The number of hospital admissions within the first year after 
discharge for IE was determined based on hospital discharge diagnosis. The highest level of 
completed education prior to admission for IE was classified according to the International 
Standard Classification of Education (i.e. basic school, high school, vocational education, 
short/medium length higher education, and long higher education or research). Average 5-
year household income prior to admission for IE was calculated and graded in quartiles. 
 
Workforce attachment 
Patients were classified as part of the workforce if they were employed, unemployed but 
capable of working (i.e. not receiving paid sick leave or disability pension or not on early 
retirement), or received state educational grants, paid maternity leave, or other leave of 
absence. Employment status 30 days prior to admission for IE was assessed based on the five 
weeks leading up to this date, and only patients who were part of the workforce were 
included in the study. Five-week evaluation periods were applied in order to reduce 


















detached from the workforce as described previously.
22, 23
 Therefore, only patients with sick 
leave of at least three out of the five evaluated weeks were classified as detached from the 
workforce. Our study design ensured that no patients could reach the state pension age during 
the study follow-up period. Further, it was possible for patients to change status (i.e. 
attachment or detachment from the workforce) at later evaluations during follow-up. 
 
Outcomes 
The primary endpoint of the study was return to the workforce estimated in the five-week 
period one year after discharge for IE. Outcomes, i.e. part of the workforce, detached from 
the workforce, and death, were assessed every 6 months for a total of two years after IE. 
 
Sensitivity analysis 
To test the robustness of our results, we varied our definition of detachment from the 
workforce to two and four out of five weeks, respectively. Further, we examined return to 
work among patients, who were employed (i.e. patients in employment and not receiving any 
social benefits) 30 days prior to IE. 
 
Statistical analyses 
Descriptive data were reported as frequencies and percentages or medians with interquartile 
range (IQR) as appropriate. Baseline characteristics were summarized separately for age 
groups (18-40, 41-55, 56-60 years) and differences between age groups were tested by 
applying the chi-square test for categorical variables. Factors associated with return to the 
workforce one year after IE were identified using logistic regression, adjusted for age, 
gender, income, education, comorbidities, admission characteristics, hospital admissions 


















year due to emigration or death were set as detached from the workforce in the logistic 
regression analysis. Relevant interactions were tested by likelihood ratio test and found not 
significant, unless otherwise stated. All statistical analyses were performed with SAS 
statistical software (SAS 9.4, SAS Institute, Cary, North Carolina, USA), and a two-sided p-
value <0.05 was considered statistically significant. 
 
Ethics 
Approval for this study was obtained by the Danish Data Protection Agency (No. 2007-58-
0015; internal reference: GEH-2014-014, I-Suite no. 02732). In Denmark, register-based 
studies in which individuals cannot be identified do not require ethical approval. No 
extramural funding was used to support this work. 
 
Results 
Between January 1, 1996 and December 31, 2013, a total of 5804 patients had a first-time 
diagnosis of IE and 1678 patients were of working age between 18-60 years and alive at 
discharge (Figure 1). Of these, 1065 (63.5%) were part of the workforce 30 days prior to 
admission and comprised the study population (Table 1). Baseline characteristics, admission 
characteristics, and hospital admissions within the first year post-discharge stratified 
according to age are summarized in Table 2 and 3, respectively. The median age of the study 
population was 48 years (IQR 18) and 73.6% were men. The median length of hospital stay 
was 43 days (IQR 21), and 42.0% underwent valve surgery during admission. Younger 
patients (age 18-40) were less likely to undergo valve surgery, had a shorter length of stay, 
had fewer comorbidities and were less likely to be men compared with older patients. 
 


















One year after discharge for IE, 765 (71.8%) patients returned to the workforce, 130 (12.2%) 
were on paid sick leave, 76 (7.1%) received disability pension, 23 (2.2%) were on early 
retirement, 65 (6.1%) had died, and 6 (0.6%) had emigrated. The proportion of patients 
returning to the workforce at one-year follow-up ranged from 62.3% to 81.3% according to 
age groups and was lowest in the oldest age group. One-year mortality was comparable 
across age groups and ranged from 5.8% to 6.3%. Over time, there was a trend towards an 
increase in the proportion of patients who were part of the workforce one year after discharge 
for IE (71.0% in the period 1996-2001,  69.1% in the period 2002-2007, and 75.4% in the 
period 2008-2013), although this association was not statistically significant (p = 0.16) 
The distribution of outcomes every 6 months for a total of two years after 
discharge for IE according to age is shown in Figure 2. The proportion of patients returning 
to the workforce over time elapsed since discharge for IE was comparable in the two 
youngest age groups and declined in the oldest age group. 
The distribution of outcomes at one-year follow-up in patients with and without 
significant comorbidities at discharge is presented in Figure 3. 149 (14.0%) patients had 
significant comorbidities (Charlson Comorbidity Index > 2) at discharge. Regardless of age, 
patients with significant comorbidities were less likely to return to the workforce compared 
with those without significant comorbidities, and the difference was most prominent in 
patients aged 41-55 years (74.3% without versus 43.7% with significant comorbidities). 
Likewise, a higher mortality was observed among patients with significant comorbidities 
compared with those without significant comorbidities. 
 
Factors associated with return to the workforce 
Results from the multivariate logistic regression for return to the workforce one year after 


















returning to the workforce were younger age, and higher level of education and income. 
Stroke during admission, longer length of hospital stay, as well as a history of chronic kidney 
disease, chronic obstructive pulmonary disease, acute myocardial infarction, and malignancy, 
and more hospital admissions within a year post-discharge were associated with a lower 
likelihood of returning to the workforce. There was a trend in the association between lower 
likelihood of returning to the workforce and a history of heart failure, hypertension, 
peripheral vascular disease, and liver disease, although not statistically significant. 
 
Sensitivity analyses 
To test the robustness of our findings, we varied our definition of detachment from the 
workforce from three to two or four out of five weeks, respectively and found no difference 
in the proportion of patients returning to the workforce one year after discharge for IE (71.1% 
and 72.0% for two and four weeks, respectively). Further, we examined return to work (i.e. 
patients in actual employment and not receiving any social benefits) among those, who were 
employed prior to IE and alive at discharge. The proportion of patients returning to work one 




In this nationwide cohort study, we examined return to the workforce in patients of working 
age between 18 and 60 years with a first-time diagnosis of IE. Our study yielded the 
following findings: First, seven out of ten patients who were part of the workforce prior to 
admission and alive at discharge returned to the workforce one year later and less than one 
out of ten died. Second, younger age and higher socioeconomic status were associated with a 


















admission, longer length of hospital stay, and additional hospital admissions within a year 
post-discharge after IE were associated with a lower likelihood of returning to the workforce. 
Previous studies suggest that a substantial part of patients treated for IE may 
experience physical and cognitive difficulties such as fatigue, physical weakness, 
concentration difficulties, and memory loss, resulting in may have impaired health-related 
quality of life and poor self-perceived physical health post-discharge.
3, 24-28
 Only a single 
questionnaire-based study has investigated employment status in 37 patients with IE and 
found that 65% were working one year after discharge.
3
 To our knowledge, our study is the 
first to examine return to the workforce after first-time IE in a large unselected cohort of 
patients on a nationwide scale. Notably, we found that more than seven out of ten patients 
who were part of the workforce 30 days prior to first-time IE returned to the workforce one 
year after discharge. A recent study found a similar proportion of patients returning to the 
workforce one year after first-time hospitalization for heart failure (68%).
23
 Among patients 
with infectious spondylodiscitis, 73% returned to the workforce within two years of follow-
up.
29
 In contrast, a higher proportion of patients returned to the workforce one year after 
community-acquired bacteremia (78%) compared with IE survivors in our study.
30
 Likewise, 
a higher proportion of patients who survived pneumococcal meningitis and viral encephalitis 
were working one year after hospitalization (93% and 84%, respectively).
31
 Thus, our 
findings reflect that patients who survive IE may be left with life-changing physical and 
mental disabilities due to the traumatic and potentially life-threatening character of the 
disease. 
Employment has important socioeconomic consequences for both the patient 
and the society, but it can also enhance recovery and life satisfaction by consolidating self-
esteem, confidence, and social identity.
7-11
 In order to prevent detachment from the workforce 


















IE is warranted. Such information is potentially of great importance as it may help to suggest 
whether more intensive rehabilitation, psychological, educational, or some other therapeutic 
intervention may enable a successful reintegration into the workforce. Despite the major 
personal and economic costs to society of not returning to work, the literature is non-existent 
in the area of rehabilitation for patients following treatment for IE and both national and 
international guidelines for the management of IE do not include any recommendations on 
rehabilitation.
1, 2
 Interventions that may impact patients’ likelihood of returning to the 
workforce should be explored further in order to restore these as best possible and with a 
minimum of lost value for society. Currently, an ongoing randomized, multicenter clinical 
trial, CopenHeart IE, is investigating the effect of comprehensive cardiac rehabilitation 
versus usual care for patients treated with IE.
32
 The results of this trial may therefore shed 
light on the effect of an integrated rehabilitation program on the physical and psychosocial 
functioning in patients treated for IE, including the ability to return to work. 
The presence of comorbidities appears to have major impact on the likelihood 
of returning to the workforce in patients surviving IE. In our study, the proportion of patients 
returning to the workforce one year post-discharge was substantially lower if significant 
comorbidities were present at discharge. However, it is important to have in mind that the 
majority of the study population was free of significant comorbidities and even a substantial 
proportion of these patients failed to return to the workforce. We also found that higher 
socioeconomic status was associated with a higher likelihood of returning to the workforce; 
individuals with a higher level of education have more financial, social, and psychological 
resources and may have a less physically demanding job – factors which may facilitate a fast 
and successful reintegration into the workforce.
33, 34
 Longer length of hospital stay and stroke 
during admission were associated with a lower likelihood of returning to the workforce as 


















admission was not statistically significantly associated with a lower likelihood of returning to 
the workforce. Our findings may encourage a multidisciplinary approach in the management 
of patients treated for IE in order to increase the chance of returning to the workforce, 
particularly in patients identified as being at high risk of workforce detachment.  
 
Strengths and limitations 
The main strength of this study is the completeness of data in a nationwide unselected cohort 
of patients with a first-time diagnosis of IE followed in a real-world setting. To appreciate the 
findings of our study, it is important to acknowledge the limitations of our study. The 
accuracy of the data relies upon the coding in nationwide administrative registries, though 
these data have previously been validated.
14
 The public health care and social benefits system 
in Denmark may hamper translation of our findings to countries with more restricted access 
to these services. Danish national guidelines for the management of patients with IE 
recommend that intravenous antibiotic therapy should be administered in-hospital, which 
may explain the long median length of hospital stay found in our study. This should be taken 
into account when translating our findings to countries with other practices. By design, no 
patients could reach the state pension age during the study follow-up period. However, the 
oldest patients did have the opportunity to retire early and receive early retirement benefits if 
the criteria for such were met; although accounting for only 2.3% of the study population, it 
is not unlikely that these patients did not return to the workforce due to lack of motivation 
and necessity rather than poor performance status. We did not have information on important 
prognostic factors such as microbiology and plasma creatinine levels or postoperative 
depression. However, this would only affect the results from the logistic regression and not 


















detached from the workforce in the logistic regression; this has most likely little to no impact 
on our results as only 0.3% of the study population emigrated. 
 
Conclusion 
One year after discharge, seven out of ten patients who survived first-time IE returned to the 
workforce and the proportion was substantially lower if significant comorbidities were 
present at discharge. A better understanding of the causes for not returning to the workforce 
is warranted and such information may suggest whether intensive rehabilitation, 
psychological or educational interventions may enable a successful reintegration into the 
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Figure 1. Flow chart of the study population selection process 
 
Figure 2. Distribution of outcomes every 6 months for a total of two years 
 
Figure 3. Distribution of outcomes at one-year follow-up according to comorbidities 
C, Significant comorbidities; NC, No significant comorbidities. 
Significant comorbidities were defined as Charlson Comorbidity Index > 2 (N=149) and no significant comorbidities as Charlson 
Comorbidity Index 0-2 (N=916). 
 
Figure 4. Results from the multivariable logistic regression examining factors associated with 
return to the workforce one year after discharge for infective endocarditis 




















Table 1. Employment status 30 days prior to first-time infective endocarditis in patients of 










In the workforce     
     Employed 770 (45.9) 182 (39.7) 390 (49.0) 198 (46.7) 
     Study/maternity leave 32 (1.9) 21 (4.6) 4 (0.5) 32 (1.7) 
     Unemployed 263 (15.7) 140 (30.6) 89 (11.2) 263 (8.0) 
Not in the workforce     
     Sick leave 131 (7.8) 23 (5.0) 68 (8.5) 131 (9.4) 
     Disability pension 472 (28.1) 92 (20.1) 245 (30.8) 472 (31.8) 





























Age (median [interquartile range]) 32 (10) 49 (8) 58 (2)  
Male 233 (67.9) 361 (74.7) 190 (79.5) < 0.01 
Income group    < 0.01 
     Q1 (lowest) 176 (51.3) 63 (13.0) 19 (7.9)  
     Q2 70 (20.4) 77 (16.0) 32 (13.4)  
     Q3 57 (16.6) 144 (29.8) 91 (38.1)  
     Q4 (highest) 40 (11.7) 199 (42.2) 97 (40.6)  
Education    < 0.01 
     Basic school 148 (43.2) 123 (25.5) 58 (24.3)  
     High school 33 (9.6) 13 (2.7) 4 (1.7)  
     Vocational education 86 (25.1) 193 (39.9) 100 (41.8)  
     Short/medium higher education 30 (8.7) 79 (16.4) 40 (16.7)  
     Long higher education 12 (3.5) 40 (8.3) 17 (7.1)  
     Unknown 34 (9.9) 35 (7.2) 20 (8.4)  
Charlson Comorbidity Index    < 0.01 
     0-2 315 (91.8) 412 (85.3) 189 (79.1)  
     > 2 28 (8.2) 71 (14.7) 50 (20.9)  
Comorbidities     
     Stroke prior to IE admission 5 (1.5) 20 (4.1) 7 (2.9) 0.08 
     Heart failure 29 (8.5) 69 (14.3) 29 (12.1) 0.04 
     Atrial fibrillation 9 (2.6) 49 (10.1) 38 (15.9) < 0.01 
     Myocardial infarction 4 (1.2) 17 (3.5) 20 (8.4) < 0.01 
     Hypertension 32 (9.3) 124 (25.7) 104 (43.5) < 0.01 
     Diabetes 7 (2.0) 23 (4.8) 22 (9.2) < 0.01 
     Peripheral vascular disease 8 (2.3) 17 (3.5) 12 (5.0) 0.22 
     Malignancy 7 (2.0) 34 (7.0) 35 (14.6) < 0.01 
     Chronic renal failure 9 (2.6) 11 (2.3) 11 (4.6) 0.20 
     Chronic obstructive pulmonary disease 5 (1.5) 14 (2.9) 11 (4.6) 0.08 


















Concomitant medical treatment     
     Oral anticoagulants 92 (26.8) 210 (43.5) 103 (43.1) < 0.01 
     Beta-blockers 40 (11.7) 112 (23.2) 82 (34.3) < 0.01 
     Calcium-blockers 16 (4.7) 61 (12.6) 43 (18.0) < 0.01 
     Renin-angiotensin-system inhibitors 25 (7.3) 95 (19.7) 75 (31.4) < 0.01 
Procedures prior to IE admission     
     Valve surgery 17 (5.0) 25 (5.2) 12 (5.0) 0.98 
     PM or ICD implantation 5 (1.5) 18 (3.7) 3 (1.3) 0.05 
Categorical variables are presented as numbers and frequencies in percentages. Information on all covariates was obtained at 
discharge unless otherwise stated. 




















Table 3. Admission characteristics and hospital admissions within the first year post-









Procedures/complications during admission     
     Valve surgery 107 (31.2) 224 (46.4) 116 (48.5) < 0.01 
     PM or ICD implantation 10 (2.9) 30 (6.2) 12 (5.0) 0.09 
     Stroke 11 (3.2) 38 (7.9) 20 (8.4) 0.01 
Length of stay     0.01 
     14-30 days 90 (26.2) 94 (19.5) 37 (15.5)  
     31-60 days 206 (60.1) 306 (63.4) 150 (62.8)  
     61-90 days 36 (10.5) 55 (11.4) 39 (16.3)  
     > 90 days 11 (3.2) 28 (5.8) 13 (5.4)  
Hospital admissions within the first year after 
discharge 
   0.48 
     None 150 (43.7) 233 (48.2) 110 (46.0)  
     1-2 136 (39.7) 162 (33.5) 84 (35.2)  
     > 2 57 (16.6) 88 (18.2) 45 (18.8)  
Valve surgery within the first year after discharge 22 (6.4) 45 (9.3) 21 (8.8) 0.31 
Categorical variables are presented as numbers and frequencies in percentages.  
PM, pacemaker; ICD, implantable cardioverter defibrillator. 
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Figure 1 
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Figure 3 
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Figure 4 
